Chemours
484 hedge funds and large institutions have $3.22B invested in Chemours in 2023 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 115 increasing their positions, 175 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% less capital invested
Capital invested by funds: $3.23B → $3.22B (-$12.1M)
6% less call options, than puts
Call options by funds: $47.1M | Put options by funds: $50M
34% less repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 175
Holders
484
Holding in Top 10
6
Calls
$47.1M
Puts
$50M
Top Buyers
| 1 | +$103M | |
| 2 | +$18.7M | |
| 3 | +$13.8M | |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$9.91M |
| 5 |
HF
HRT Financial
New York
|
+$9.01M |
Top Sellers
| 1 | -$26.3M | |
| 2 | -$23.2M | |
| 3 | -$22.8M | |
| 4 |
Legal & General Group
London,
United Kingdom
|
-$21M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$14M |